This company has been marked as potentially delisted and may not be actively trading. NASDAQ:DRAD Digirad (DRAD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Digirad Stock (NASDAQ:DRAD) Get Digirad alerts:Sign Up Key Stats Today's Range$2.02▼$2.1450-Day Range$2.79▼$4.6552-Week Range$1.99▼$8.84Volume2.25 million shsAverage Volume485,592 shsMarket Capitalization$10.14 millionP/E RatioN/ADividend Yield103.29%Price TargetN/AConsensus RatingN/A Company Overview Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through five segments: Diagnostic Services, Diagnostic Imaging, Mobile Healthcare, Building and Construction, and Real Estate and Investments. The company offers imaging and monitoring services to healthcare providers; and contract diagnostic imaging, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. It also develops, sells, and maintains solid-state gamma cameras, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance contract services. In addition, it manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; and manages real estate assets and investments. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia. Read More Receive DRAD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Digirad and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRAD Stock News HeadlinesCatalyst MedTech Unveils Expanded Digirad® Portfolio, Imaging Innovation Showcase, and Long-Term Support Strategy at SNMMI 2026May 26, 2026 | globenewswire.comApril 19th Options Now Available For Karuna Therapeutics (KRTX)January 7, 2024 | nasdaq.comBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.August 3 at 1:00 AM | Chaikin Analytics (Ad)2 girls dead, 1 hospitalized after possible overdoses at high schoolMay 20, 2023 | cbsnews.comConnecticut teachers thought 5-year-old boy was just 'playing dead' before he died, lawsuit claimsApril 23, 2023 | usatoday.comLisa Marie Presley dead at 54 after cardiac arrest: ‘My beautiful daughter’January 16, 2023 | nypost.comNRock icon Jeff Beck dead at 78January 14, 2023 | foxnews.comGlobal Nuclear Medicine Equipment Market Report to 2030 - Featuring Siemens Healthineers, Fujifilm Holdings, Canon and Digirad Among Others - ResearchAndMarkets.com - Business WireOctober 12, 2022 | businesswire.comSee More Headlines DRAD Stock Analysis - Frequently Asked Questions How were Digirad's earnings last quarter? Digirad Co. (NASDAQ:DRAD) released its quarterly earnings data on Wednesday, November, 18th. The medical equipment provider reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of $0.15 by $0.34. The medical equipment provider had revenue of $30.35 million for the quarter. Digirad had a negative trailing twelve-month return on equity of 3.75% and a negative net margin of 5.32%. When did Digirad's stock split? Shares of Digirad reverse split on Wednesday, June 5th 2019.The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of Digirad own? Based on aggregate information from My MarketBeat watchlists, some other companies that Digirad investors own include AT&T (T), GE Aerospace (GE), Gilead Sciences (GILD), Exelixis (EXEL), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL). Company Calendar Last Earnings11/18/2020Today8/03/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:DRAD CIK707388 Webwww.digirad.com Phone858-726-1600FaxN/AEmployees618Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$4.63 million Net Margins-5.32% Pretax MarginN/A Return on Equity-3.75% Return on Assets-0.85% Debt Debt-to-Equity Ratio0.88 Current Ratio1.27 Quick Ratio0.91 Sales & Book Value Annual Sales$114.18 million Price / Sales0.09 Cash Flow$3.09 per share Price / Cash Flow0.69 Book Value$10.30 per share Price / Book0.21Miscellaneous Outstanding Shares4,760,000Free FloatN/AMarket Cap$10.14 million OptionableNot Optionable Beta0.18 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:DRAD) was last updated on 8/3/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored“The unseen winner of the AI race” is not SpaceXMarc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Digirad Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Digirad With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
